Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anilkumar Pillai

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Molecular Psychiatry|April 4, 2024
Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?Brandi Quintanilla, Carlos A Zarate, Anilkumar Pillai
Current Neuropharmacology|March 27, 2014
Glucocorticoid regulates parkin expression in mouse frontal cortex: implications in schizophreniaChirayu D Pandya, Amanda Crider, Anilkumar Pillai
Molecular Neuropsychiatry|December 13, 2017
Altered Expression of Endoplasmic Reticulum Stress-Related Genes in the Middle Frontal Cortex of Subjects with Autism Spectrum DisorderAmanda Crider, Anthony O Ahmed, Anilkumar Pillai
Frontiers in Neuroscience|September 15, 2023
Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in ratsAshutosh Tripathi, Henry A Nasrallah, Anilkumar Pillai
Physiology & Behavior|November 10, 2010
Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in ratsAlvin V Terry, Ammar Kutiyanawalla, Anilkumar Pillai
Plos One|November 1, 2011
Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatmentAmmar Kutiyanawalla, Alvin V Terry, Anilkumar Pillai
Asian Journal of Psychiatry|February 6, 2013
BDNF-TrkB signaling and neuroprotection in schizophreniaChirayu D Pandya, Ammar Kutiyanawalla, Anilkumar Pillai
Plos One|June 8, 2011
Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortexKristy R Howell, Ammar Kutiyanawalla, Anilkumar Pillai
The Journal of ECT|May 10, 2014
The antipsychotic effects of ECT: a review of possible mechanismsPeter B Rosenquist, Brian Miller, Anilkumar Pillai
Neuroscience Letters|August 7, 2013
VEGF activates NR2B phosphorylation through Dab1 pathwayKristy R Howell, Md Nusrul Hoda, Anilkumar Pillai
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Molecular Psychiatry|April 4, 2024
Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?Brandi Quintanilla, Carlos A Zarate, Anilkumar Pillai
Current Neuropharmacology|March 27, 2014
Glucocorticoid regulates parkin expression in mouse frontal cortex: implications in schizophreniaChirayu D Pandya, Amanda Crider, Anilkumar Pillai
Molecular Neuropsychiatry|December 13, 2017
Altered Expression of Endoplasmic Reticulum Stress-Related Genes in the Middle Frontal Cortex of Subjects with Autism Spectrum DisorderAmanda Crider, Anthony O Ahmed, Anilkumar Pillai
Frontiers in Neuroscience|September 15, 2023
Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in ratsAshutosh Tripathi, Henry A Nasrallah, Anilkumar Pillai
Physiology & Behavior|November 10, 2010
Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in ratsAlvin V Terry, Ammar Kutiyanawalla, Anilkumar Pillai
Plos One|November 1, 2011
Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatmentAmmar Kutiyanawalla, Alvin V Terry, Anilkumar Pillai
Asian Journal of Psychiatry|February 6, 2013
BDNF-TrkB signaling and neuroprotection in schizophreniaChirayu D Pandya, Ammar Kutiyanawalla, Anilkumar Pillai
Plos One|June 8, 2011
Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortexKristy R Howell, Ammar Kutiyanawalla, Anilkumar Pillai
The Journal of ECT|May 10, 2014
The antipsychotic effects of ECT: a review of possible mechanismsPeter B Rosenquist, Brian Miller, Anilkumar Pillai
Neuroscience Letters|August 7, 2013
VEGF activates NR2B phosphorylation through Dab1 pathwayKristy R Howell, Md Nusrul Hoda, Anilkumar Pillai
Pageof 11